Delivery Order SPE2DB20D3101-SPE2DB22FQVT1
- Not listed
- This federal contract award, valued at $4,917.98, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ciprofloxacin HCL 250 mg tablets, a pharmaceutical product used for various medical applications. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which is valued at $999,999,999 and runs through...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,563,681,935 units of Ciprofloxacin HCL 250 mg tablets. The contract has a ceiling value of $4,407.09 and a completion date of February 16, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,544.44, is for the delivery of Ciprofloxacin HCL 500 mg tablets. It is a firm-fixed-price delivery order contract with a completion date of March 26, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ciprofloxacin HCl 500 mg tablets. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which serves as a primary vehicle for DLA to procure a comprehensive range of medical commodities to support military treatment programs and...
- This federal contract award is for the delivery of 4,565,134,643 units of ciprofloxacin HCl 250 mg tablets in 100-count bottles. The contract, valued at $15,735.10, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Firm Fixed Price Delivery Order with a period of performance ending on July 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
- This federal contract award is for the delivery of 4,557,636 units of Ciprofloxacin HCL 250 mg tablets to the Defense Logistics Agency (DLA). The $1,429.57 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on June 24, 2022, with a completion date of June 27, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award is for the delivery of 4,558,280,789 units of Ciprofloxacin HCL 250 mg tablets to the Defense Logistics Agency (DLA). The $1,032.68 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 30, 2022, with an ultimate completion date of August 31, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle...
- This federal contract award, with ID SPE2DB20D3101 | SPE2DB21FK4T7, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,554,704,070 units of Ciprofloxacin HCL 250 MG tablets, a critical antibiotic medication. The contract has a ceiling value of $1,151.63 and was awarded on September 8, 2021, with a completion date of September 9, 2021. Amerisourcebergen Drug Corp holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,221,038 units of Ciprofloxacin HCL 500 mg tablets. The delivery order has a ceiling value of $3,243.16 and a performance period ending on July 24, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,808.86, is a delivery order for 4,559,295,117 units of Ciprofloxacin HCL 250 MG Tablets. It is a firm-fixed price contract with a completion date of December 8, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999,...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB22FQVT1Delivery Order
This federal contract award, valued at $7,343.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ciprofloxacin HCL 250 mg tablets in quantities of 100, with a completion date of September 26, 2022. This contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 9/23/22 |